Finance

Lists
ROSSARI:NSE
Rossari Biotech Ltd
506,65 INR
+0,13%
(+0,65) 1D
30 ივლ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ROSSARI...
Open
505,00 INR
High
515,95 INR
Low
505,00 INR
Mkt. cap
28,07 მლრდ.
Avg. vol.
120,40 ათ.
Volume
34,35 ათ.
Dividend
0,10%
Quarterly dividend
0,12 INR
Ex-dividend date
10 ივლ. 2026
P/E ratio
18,63
52-wk high
713,60 INR
52-wk low
375,00 INR
EPS
27,20 INR
No. of employees
585
Open
505,00 INR
High
515,95 INR
Low
505,00 INR
Mkt. cap
28,07 მლრდ.
Avg. vol.
120,40 ათ.
Volume
34,35 ათ.
Dividend
0,10%
Quarterly dividend
0,12 INR
Ex-dividend date
10 ივლ. 2026
P/E ratio
18,63
52-wk high
713,60 INR
52-wk low
375,00 INR
EPS
27,20 INR
No. of employees
585
News stories
From sources across the web
Profile
Rossari Biotech is an Indian chemical manufacturing company with a focus on specialty chemicals. It is also engaged in production of specialty enzymes and chemicals in India that is used in the pharmaceuticals, paper, construction, textiles, nutrition and animal health industries. The company was started in 2003 as a partnership firm titled Rossari Labtech and was incorporated into a company in 2009 and was renamed as Rossari Biotech. It has two R&D facilities, one at Silvassa manufacturing facility and the second in Dahej. Wikipedia
About Rossari Biotech Ltd
CEO-
Employees585
Founded10 აგვ. 2009
Headquarters-
SectorSpeciality chemicals
Websiterossari.com
Last report
20 ივლ. 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
6,33 INR / 8,80 INR
-28,07%miss
Revenue / Est. (INR)
6,97 მლრდ. / 6,71 მლრდ.
+3,87%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
5,86 მლრდ.
5,82 მლრდ.
6,85 მლრდ.
6,97 მლრდ.
Cost of goods sold
4,01 მლრდ.
4,01 მლრდ.
5,04 მლრდ.
4,91 მლრდ.
Cost of revenue
4,01 მლრდ.
4,01 მლრდ.
5,04 მლრდ.
4,91 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
377,99 მლნ.
402,56 მლნ.
463,26 მლნ.
440,44 მლნ.
Operating expense
1,32 მლრდ.
1,32 მლრდ.
1,44 მლრდ.
1,51 მლრდ.
Total operating expenses
5,32 მლრდ.
5,32 მლრდ.
6,48 მლრდ.
6,42 მლრდ.
Operating income
536,91 მლნ.
492,59 მლნ.
369,04 მლნ.
550,05 მლნ.
Other non operating income
16,04 მლნ.
5,09 მლნ.
-27,71 მლნ.
31,87 მლნ.
EBT including unusual items
496,72 მლნ.
425,01 მლნ.
642,43 მლნ.
476,72 მლნ.
EBT excluding unusual items
496,72 მლნ.
425,01 მლნ.
437,87 მლნ.
476,72 მლნ.
Income tax expense
127,96 მლნ.
97,27 მლნ.
182,76 მლნ.
125,77 მლნ.
Effective tax rate
25,76%
22,89%
28,45%
26,38%
Other operating expenses
755,29 მლნ.
717,50 მლნ.
736,59 მლნ.
817,11 მლნ.
Net income
368,76 მლნ.
327,74 მლნ.
459,67 მლნ.
350,95 მლნ.
Net profit margin
6,29%
5,63%
6,71%
5,03%
Earnings per share
6,65
5,91
8,29
6,33
Interest and investment income
-
-
13,51 მლნ.
-
Interest expense
-60,91 მლნ.
-76,65 მლნ.
-90,59 მლნ.
-109,77 მლნ.
Net interest expenses
-60,91 მლნ.
-76,65 მლნ.
-77,08 მლნ.
-109,77 მლნ.
Depreciation and amortization charges
182,33 მლნ.
196,14 მლნ.
235,28 მლნ.
256,15 მლნ.
EBITDA
716,82 მლნ.
645,98 მლნ.
544,80 მლნ.
725,80 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer